Biocon Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Biocon Limited launches its Glucagon-like Peptide-1 (GLP -1), Liraglutide, in the Netherlands".
Biocon Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Biocon Limited launches its Glucagon-like Peptide-1 (GLP -1), Liraglutide, in the Netherlands".